Arash Najafian
1* 
, Sadaf Esteki
1 1 Clinical Research Development Center, Najafabad Branch, Islamic Azad University, Najafabad, Iran
Abstract
Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.